Publications

Antibody dual-functionalisation enabled through a modular divinylpyrimidine disulfide rebridging strategy.

Authors: AR Hanby, SJ Walsh, AJ Counsell, N Ashman, KT Mortensen, JS Carroll, DR Spr...

Research group: Carroll Group

E-pub date: 18 Aug 2022

Journal name: Chem Commun (Camb)

Metabolic Glycan Labeling of Cancer Cells Using Variably Acetylated Monosaccharides.

Authors: DR Parle, F Bulat, S Fouad, H Zecchini, KM Brindle, AA Neves, FJ Leeper

Research group:

E-pub date: 17 Aug 2022

Journal name: Bioconjug Chem

Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models.

Authors: CM Sauer, K Heider, J Belic, SE Boyle, JA Hall, D-L Couturier, A An, A Vija...

Research group: Brenton Group,

E-pub date: 8 Aug 2022

Journal name: EMBO Mol Med

Relationships between genome-wide R-loop distribution and classes of recurrent DNA breaks in neural stem/progenitor cells.

Authors: S Thongthip, A Carlson, MP Crossley, B Schwer

Research group: Crossley Group

E-pub date: 4 Aug 2022

Journal name: Sci Rep

All-in-one disulfide bridging enables the generation of antibody conjugates with modular cargo loading.

Authors: FM Dannheim, SJ Walsh, CT Orozco, AH Hansen, JD Bargh, SE Jackson, NJ Bond,...

Research group: Carroll Group

E-pub date: 4 Aug 2022

Journal name: Chem Sci

Quantitative DNA-RNA Immunoprecipitation Sequencing with Spike-Ins.

Authors: MP Crossley, KA Cimprich

Research group: Crossley Group

E-pub date: 1 Aug 2022

Journal name:

Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.

Authors: L Rundo, L Beer, L Escudero Sanchez, M Crispin-Ortuzar, M Reinius, C McCagu...

Research group: Markowetz Group, Brenton Group

E-pub date: 1 Aug 2022

Journal name: Front Oncol

Magnetization transfer imaging of ovarian cancer: initial experiences of correlation with tissue cellularity and changes following neoadjuvant chemotherapy.

Authors: SS Deen, MA McLean, AB Gill, RAF Crawford, J Latimer, P Baldwin, HM Earl, C...

Research group: Brenton Group

E-pub date: 1 Aug 2022

Journal name: BJR Open

Filters

Research Groups

Core Facilities

Start date

End date

Antibody dual-functionalisation enabled through a modular divinylpyrimidine disulfide rebridging strategy.

Metabolic Glycan Labeling of Cancer Cells Using Variably Acetylated Monosaccharides.

Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models.

Relationships between genome-wide R-loop distribution and classes of recurrent DNA breaks in neural stem/progenitor cells.

All-in-one disulfide bridging enables the generation of antibody conjugates with modular cargo loading.

Quantitative DNA-RNA Immunoprecipitation Sequencing with Spike-Ins.

Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.

Magnetization transfer imaging of ovarian cancer: initial experiences of correlation with tissue cellularity and changes following neoadjuvant chemotherapy.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Antibody dual-functionalisation enabled through a modular divinylpyrimidine disulfide rebridging strategy.

Metabolic Glycan Labeling of Cancer Cells Using Variably Acetylated Monosaccharides.

Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models.

Relationships between genome-wide R-loop distribution and classes of recurrent DNA breaks in neural stem/progenitor cells.

All-in-one disulfide bridging enables the generation of antibody conjugates with modular cargo loading.

Quantitative DNA-RNA Immunoprecipitation Sequencing with Spike-Ins.

Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.

Magnetization transfer imaging of ovarian cancer: initial experiences of correlation with tissue cellularity and changes following neoadjuvant chemotherapy.